Direktorat Registrasi ObatValid

RANITIDINE HCL

Claim this product
BPOM Number
GKL0405038743A1
Approved
21 November 2024
Expiry
16 May 2026
Form
INJEKSI; 28 mg

About This Registration

RANITIDINE HCL is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL0405038743A1. Its current registration status is Valid, with the licence valid until 16 May 2026. The product is registered to DEXA MEDICA - INDONESIA. BPOM first approved this registration in May 2021. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
Registrasi Obat
Packaging
DUS, 25 AMPUL @ 2 ML
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Ingredients (1)

RANITIDINE HYDROCHLORIDE

Market Intelligence

Owner Portfolio
DEXA MEDICA - INDONESIA holds 535 BPOM registrations
Manufacturer Scale
DEXA MEDICA - INDONESIA produces 535 registered products
Registration Age
Registered for 5 years, 4 months
Expiry Status
Expired 131 days ago

FDA Cross-Reference

via openFDA
Generic Name
RANITIDINE
Product Type
HUMAN OTC DRUG
Route of Administration
ORAL
Purpose
Purpose Acid reducer

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1